Policy Watch: 27 Regulatory Updates — March 16, 2026
This Policy Watch covers the DEA temporary schedule I placement and 27 regulatory updates as of March 16, 2026. These updates include synthetic opioids and benzodiazepine analogs relevant to cannabis clinicians. Stay informed on controlled substances…
West Virginia House Approves Medical Cannabis Edibles Bill
West Virginia medical cannabis program expands to include edible formulations, offering patients improved access and treatment options. Edibles provide pharmacokinetic advantages for those with respiratory issues or needing longer symptom relief. This…
Challenges with Nebraska Medical Cannabis Regulations
Nebraska medical cannabis regulations have introduced new restrictions on plant parts and THC concentration limits. These rules impact patient access and physician licensure requirements. Patients may face limited therapeutic options due to these…
The House Committee on Dangerous Drugs and Health Advances Medical Cannabis Framework
The medical cannabis framework Philippines is advancing aims to establish regulatory systems for qualified patients. This legislative effort supports cannabinoid therapies for conditions like chronic pain and epilepsy. The framework ensures patient…